ACTIV-1 IM: Randomized Master Protocol for Immune Modulators for Treating COVID-19

Project: Research project

Project Details

StatusActive
Effective start/end date8/17/208/16/21

Funding

  • Duke University (SA-D401-02//HHSO100201400002I)
  • Biomedical Advanced Research and Development Authority (SA-D401-02//HHSO100201400002I)